Terms: = Liver cancer AND DDR2, NTRKR3, 4921, ENSG00000162733, Q16832, MIG20a, TYRO10 AND Prognosis
4 results:
1. LncRNA CEBPA-DT promotes liver cancer metastasis through ddr2/β-catenin activation via interacting with hnRNPC.
Cai Y; Lyu T; Li H; Liu C; Xie K; Xu L; Li W; Liu H; Zhu J; Lyu Y; Feng X; Lan T; Yang J; Wu H
J Exp Clin Cancer Res; 2022 Dec; 41(1):335. PubMed ID: 36471363
[TBL] [Abstract] [Full Text] [Related]
2. DNA Damage Repair Status Predicts Opposite Clinical prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma.
Chen Y; Wang X; Deng X; Zhang Y; Liao R; Li Y; Yang H; Chen K
Front Immunol; 2021; 12():676922. PubMed ID: 34335575
[TBL] [Abstract] [Full Text] [Related]
3. Parity predisposes breasts to the oncogenic action of PAPP-A and activation of the collagen receptor ddr2.
Slocum E; Craig A; Villanueva A; Germain D
Breast Cancer Res; 2019 May; 21(1):56. PubMed ID: 31046834
[TBL] [Abstract] [Full Text] [Related]
4. ddr2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1.
Xie B; Lin W; Ye J; Wang X; Zhang B; Xiong S; Li H; Tan G
J Exp Clin Cancer Res; 2015 Sep; 34(1):101. PubMed ID: 26362312
[TBL] [Abstract] [Full Text] [Related]
